人肺腺癌细胞NCI-H1975FH0086
价格：￥电议
品牌名称：富衡型号：FH0086 原产地：中国大陆 更新时间：2026/10/21 7:56:21
产品摘要：NCI-H1975细胞系于1988年7月建株，来源于一位不吸烟女性肺腺癌患者的肿瘤组织。该细胞是一种非常重要的人肺腺癌细胞系，尤其在非小细胞肺癌的靶向治疗和耐药机制研究中扮演着关键角色。
支付方式：
- 支付宝 微信 银行转账
产品完善度： 访问次数：772
企业档案
会员类型：旗舰版
已获得阿仪网信誉 等级评定
61成长值
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
阿仪网旗舰版会员：3年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
参观次数：630501
详细内容
| 产品名称 | 人肺腺癌细胞；NCI-H1975 (STR) |
|---|---|
| 品牌 | FuHeng |
| 英文名 | NCI-H1975 (STR) |
| 货号 | FH0086 |
| 规格 | 1×10⁶cells/T25培养瓶 |
| 价格 | 1500.0 |
| 培养 | RPMI1640+10%FBS |
| 别称 | H1975; H-1975; NCIH1975 |
| 形态特征 | 上皮细胞样 |
| 生长特性 | 贴壁生长 |
| 培养条件 | 气相：空气，95%；CO2,5%温度：37℃ |
| 传代方法 | 消化3-4分钟，1:2传代 |
| 组织来源 | 肺腺癌 |
| 细胞简介 | NCI-H1975 细胞系是源自美国非小细胞肺癌患者的经典肺腺癌细胞模型 |
| 特征特性 | 这株细胞于1988年七月建株。组织提供者是一位非吸烟人士。 |
| 培养基 | NCI-H1975完全培养基 |
上海衡生物科技有限公司
上海富衡生物科技有限公司（以下简称“富衡”）是主要从事生物科技，医药科技领域内的技术开发，技术咨询，技术服务的高新技术企业。是一家专注于细胞相关技术，服务及产品的高科技生命科学和生物技术领域企业。
富衡提供专业的细胞鉴定服务（采用ATCC细胞鉴定准－－STR基因分型技术），并建立完善鉴定，种类齐全的细胞资源库，能为广大科研工作者在发表高质量文章时提供可靠的“细胞鉴定依据”。公司拥有一个蓬勃朝气的年轻团队，不断进取，我们密切注视细胞技术领域的发展，并且于员工的技术和素质培训。团队中博士硕士以上学历人士达80％，有很强的技术支持及研发能力。
专注于细胞培养 PARTNERS 合作伙伴
富衡相关文献
| 论文标题 | DOI | 发表时间 | 期刊 | 影响因子 | 作者列表 |
| HHIPL2 positively governs Hedgehog signaling to accelerate non-small cell lung cancer progression via enhancing HNRNPC-mediated HNF1A mRNA stabilization | 10.1038/s41419-025-08331-3 | 2025-12-18 | Cell Death & Disease | 9.6 | Mu Ning, Liu Fanrong, Song Xiangqing, Wang Biao, Zhu Yilin, Li Lingbing, Yang Lingxiao, Sui Huacong, Wang Jinfu, Gao Fengyuan, Zhou Yongjia, Lv Yanfeng, Tian Zhongxian, Li Peichao, Zhao Xiaogang |
| DNMT3b promotes proliferation and invasion by mediating HOPX DNA methylation in lung cancer | 10.1016/j.isci.2025.114347 | 2025-12-04 | iScience | 4.1 | Kelei Guan, Songfeng Zhao, Guizhen Zhang, Yun Wang, Dongdong Song, Yanxia Ding |
| Ticagrelor inhibits the growth of lung adenocarcinoma by downregulating SYK expression and modulating the PI3K/AKT pathway | 10.1038/s41598-025-02721-5 | 2025-05-20 | Scientific Reports | 3.9 | Song Yuanhong, He Suwei, Zeng Lanhui, He Yuanqiao, Huang Ling |
| Mitochondrial CCN1 drives ferroptosis via fatty acid β-oxidation | 10.1016/j.devcel.2025.04.004 | 2025-04-24 | DEVELOPMENTAL CELL | 8.7 | Wanxin Guo, Congcong Zhang, Qianjun Zhou, Tianxiang Chen, Xin Xu, Jianfeng Zhang, Xuewen Yu, Han Wu, Xiao Zhang, Lifang Ma, Kun Qian, Daniel J. Klionsky, Rui Kang, Guido Kroemer, Yongchun Yu, Daolin Tang, Jiayi Wang |
| TRIM6 Promotes Cell Cycle and Growth by Modulating p53 Signaling Pathway in Lung Adenocarcinoma | 10.2147/IJGM.S497383 | 2025-04-12 | International Journal of General Medicine | 2.0 | Xi Lu, Haifeng Wang, Tingting Yu |
| Tumor-derived immunoglobulin-like tranｓcript 3 inhibition reshapes the immunosuppressive tumor microenvironment and potentiates programmed cell death ligand 1 blockade immunotherapy in lung adenocarcinoma | 10.1016/j.tranon.2025.102381 | 2025-04-08 | Translational Oncology | 4.1 | Leirong Wang, Qing Li, Yanxin Sun, Shuyun Wang, Xuebing Fu, Xiufen Wang, Yan Zheng, Aiqin Gao, Yuping Sun, Juan Li |
| Significance of Ribonucleoside-diphosphate Reductase Subunit M2 in Lung Adenocarcinoma | 10.2174/0115665232286359240611051307 | 2025-04-01 | CURRENT GENE THERAPY | 3.3 | Xiao-Jun Wang, Yun-Xia Huo, Peng-Jun Yang, Jing Gao, Wei-Dong Hu |
| The mechanism of E3 ubiquitin ligase HERC1 regulating ferroptosis in lung adenocarcinoma cells | 10.1016/j.cancergen.2025.02.001 | 2025-02-03 | Cancer Genetics | 2.1 | Fei Ye, Yi Xu, Xujuan Zhu, Qifeng Ding, Yifei Wang, Songhua Lu, Yongbing Chen |
| Downregulation of the m6A reader YTHDC2 upregulates exosome content in lung adenocarcinoma via inhibiting IFIT and OAS family members | 10.1016/j.jbc.2024.107783 | 2024-09-18 | JOURNAL OF BIOLOGICAL CHEMISTRY | 4.0 | Zhixin Yin, Lifang Ma, Xiaoting Tian, Qi Sun, Congcong Zhang, Yikun Wang, Yayou Miao, Xiangfei Xue, Yongjie Wang, Jiayi Wang, Xiao Zhang, Xumin Hou |
| Prognostic and immunotherapeutic significances of M2 macrophage-related genes signature in lung cancer | 10.7150/jca.98044 | 2024-07-22 | Journal of Cancer | 3.3 | Wu Haixia, Yu Yilin, Wang Wei, Lin Gen, Lin Shaolin, Zhang Jiguang, Yu Zhaojun, Luo Jiewei, Ye Deju, Chi Wu, Lin Xing |
| CCT6A facilitates lung adenocarcinoma progression and glycolysis via STAT1/HK2 axis | 10.1186/s12967-024-05284⁻⁷ | 2024-05-15 | Journal of Translational Medicine | 6.1 | Shao-Kun Yu, Tao Yu, Yu-Ming Wang, Ao Sun, Jia Liu, Kai-Hua Lu |
| Gefitinib ｍmbedbolism-related lncRNAs for the prediction of prognosis, tumor microenvironment and drug sensitivity in lung adenocarcinoma | 10.1038/s41598-024-61175-3 | 2024-05-06 | Scientific Reports | 3.8 | Guo Zishun, Zhang Xin, Yang Dingtao, Hu Zhuozheng, Wu Jiajun, Zhou Weijun, Wu Shuoming, Zhang Wenxiong |
| Nickel chloride promotes lung cancer invasion and ｍmbedstasis by up-regulating the expression of E3 ubiquitin ligase TRIM31 through the IL-6/STAT3 signaling axis | 10.1016/j.lfs.2023.122111 | 2023-09-19 | LIFE SCIENCES | 6.1 | Yongbin Lu, Fei Su, Zhiyuan Cheng, Jingli Yang, Huanyu Dai, Jingru Yang, Tao Zhang, Yana Bai |
| LPCAT3 is tranｓcriptionally regulated by YAP/ZEB/EP300 and collaborates with ACSL4 and YAP to determine ferroptosis sensitivity | 10.1089/ars.2023.0237 | 2023-05-11 | ANTIOXIDANTS & REDOX SIGNALING | 6.6 | Mr. Jiangtao Cui, Dr. Yikun Wang, Ms. Xiaoting Tian, Ms. Yayou Miao, Prof. Lifang Ma, Ms. Congcong Zhang, Dr. Xin Xu, Dr. Jiayi Wang, Prof. Wentao Fang, Prof. Xiao Zhang |
| A positive feedback circuit between RN7SK snRNA and m6A readers is essential for tumorigenesis | 10.1016/j.ymthe.2022.12.013 | 2022-12-24 | MOLECULAR THERAPY | 12.91 | Xin Xu, Lifang Ma, Xiao Zhang, Susu Guo, Wanxin Guo, Yikun Wang, Shiyu Qiu, Xiaoting Tian, Yayou Miao, Yongchun Yu, Jiayi Wang |
| Integrated Clinical and Prognostic Analysis of the m6A RNA Methylation Regulator YTHDF3 in Pan-Cancer and its Correlation with Cancer Cell Proliferation | 10.7150/jca.78403 | 2022-11-21 | Journal of Cancer | 4.478 | Cao Leiqun, Zeng Bingjie, Wang Yulan, Wang Xianzhao, Qin Yueyang, Zhang Congcong, Wu Mengyi, Wang Jiayi, Zhang Xiao, Ma Lifang |
| YAP 5-methylcytosine modification increases its mRNA stability and promotes the tranｓcription of exosome secretion-related genes in lung adenocarcinoma | 10.1038/s41417-022-00533⁻⁷ | 2022-09-19 | CANCER GENE THERAPY | 5.854 | Yu Wenjun, Zhang Congcong, Wang Yikun, Tian Xiaoting, Miao Yayou, Meng Fanyu, Ma Lifang, Zhang Xiao, Xia Jinjing |
| ISGylation of EMD promotes its interaction with PDHA to inhibit aerobic oxidation in lung adenocarcinoma | 10.1111/jcmm.17536 | 2022-09-07 | JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | 5.295 | Congcong Zhang, Jiangtao Cui, Leiqun Cao, Xiaoting Tian, Yayou Miao, Yikun Wang, Shiyu Qiu, Wanxin Guo, Lifang Ma, Jinjing Xia, Xiao Zhang |
| N-mytistoyltransferase 1 and 2 are potential tumor suppressors and novel targets of miR-182 in human non-small cell lung carcinomas | 10.1016/j.lungcan.2022.07.021 | 2022-07-29 | LUNG CANCER | 6.081 | Tong Zhang, Arul Goel, Xin Xu, Yazhou Wu, Erjiang Tang, Fanping Zhang, Yuan Li, Hanhua Li, Yuchan Cai, Wenhao Weng |
| Essential roles of exosome and circRNA_101093 on ferroptosis desensitization in lung adenocarcinoma | 10.1002/cac2.12275 | 2022-02-20 | Cancer Communications | 15.283 | Xiao Zhang, Yunhua Xu, Lifang Ma, Keke Yu, Yongjie Niu, Xin Xu, Yi Shi, Susu Guo, Xiangfei Xue, Yikun Wang, Shiyu Qiu, Jiangtao Cui, Hong Wang, Xiaoting Tian, Yayou Miao, Fanyu Meng, Yongxia Qiao, Yongchun Yu, Jiayi Wang |
| ELK1 Promotes Epithelial-Mesenchymal Transition and the Progression of Lung Adenocarcinoma by Upregulating B7-H3 | 10.1155/2021/2805576 | 2021-12-21 | Oxidative Medicine and Cellular Longevity | 6.543 | Ting-ting Yu, Tao Zhang, Fei Su, Ying-long Li, Li Shan, Xiao-ming Hou, Ruo-zheng Wang |
| Tranｓcriptional Repression of Ferritin Light Chain Increases Ferroptosis Sensitivity in Lung Adenocarcinoma | 10.3389/fcell.2021.719187 | 2021-10-26 | Frontiers in Cell and Developmental Biology | 6.684 | Wang Yikun, Qiu Shiyu, Wang Hong, Cui Jiangtao, Tian Xiaoting, Miao Yayou, Zhang Congcong, Cao Leiqun, Ma Lifang, Xu Xin, Qiao Yongxia, Zhang Xiao |
| Design, synthesis, and biological evaluation of hydroxamic acid-substituted 2,4-diaryl aminopyrimidines as potent EGFRT790M/L858R inhibitors for the treatment of NSCLC | 10.1016/j.bioorg.2021.105045 | 2021-05-31 | BIOORGANIC CHEMISTRY | 5.275 | Lixue Chen, Yunhao Zhang, Changyuan Wang, Zeyao Tang, Qiang Meng, Hunjun Sun, Yan Qi, Xiaodong Ma, Lei Li, Yanxia Li, Youjun Xu |
| Targeting SLC3A2 subunit of system XC− is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma | 10.1016/j.freeradbiomed.2021.03.023 | 2021-03-27 | FREE RADICAL BIOLOGY AND MEDICINE | 7.376 | Lifang Ma, Xiao Zhang, Keke Yu, Xin Xu, Tianxiang Chen, Yi Shi, Yikun Wang, Shiyu Qiu, Susu Guo, Jiangtao Cui, Yayou Miao, Xiaoting Tian, Lutao Du, Yongchun Yu, Jinjing Xia, Jiayi Wang |
| Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma | 10.7150/thno.55482 | 2021-03-24 | Theranostics | 11.556 | Xiao Zhang, Keke Yu, Lifang Ma, Zijun Qian, Xiaoting Tian, Yayou Miao, Yongjie Niu, Xin Xu, Susu Guo, Yueyue Yang, Zhixian Wang, Xiangfei Xue, Chuanjia Gu, Wentao Fang, Jiayuan Sun, Yongchun Yu, Jiayi Wang |
| The m6A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function | 10.1016/j.redox.2020.101801 | 2020-11-18 | Redox Biology | 9.986 | Lifang Ma, Tianxiang Chen, Xiao Zhang, Yayou Miao, Xiaoting Tian, Keke Yu, Xin Xu, Yongjie Niu, Susu Guo, Congcong Zhang, Shiyu Qiu, Yongxia Qiao, Wentao Fang, Lutao Du, Yongchun Yu, Jiayi Wang |
| Identification of 2(1H)-pyrimidinones as potential EGFR T790M inhibitors for the treatment of gefitinib-resistant non-small cell lung cancer | 10.1016/j.bioorg.2019.102994 | 2019-05-18 | BIOORGANIC CHEMISTRY | 3.926 | Jianping Huang, Jiaxin Huang, Ning Wang, Luhong Wang, Lei Li, Changyuan Wang, Xiuli Sun, Yongming Li, Guoping Huang, Xiaodong Ma |
| Structure-based modification of carbonyl-diphenylpyrimidines (Car-DPPYs) as a novel focal adhesion kinase (FAK) inhibitor against various stubborn cancer cells | 10.1016/j.ejmech.2019.04.004 | 2019-04-02 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 4.833 | Luhong Wang, Min Ai, Jiawen Yu, Lingling Jin, Changyuan Wang, Zhihao Liu, Xiaohong Shu, Zeyao Tang, Kexin Liu, Hui Luo, Wenshun Guan, Xiuli Sun, Xiaodong Ma |
| The synthesis of 4-arylamido-2-arylaminoprimidines as potent EGFR T790M/L858R inhibitors for NSCLC | 10.1016/j.bmc.2018.11.009 | 2018-11-10 | BIOORGANIC & MEDICINAL CHEMISTRY | 2.881 | Lixue Chen, Fuyun Chi, Tong Wang, Ning Wang, Wei Li, Kexin Liu, Xiaohong Shu, Xiaodong Ma, Youjun Xu |
| New acrylamide-substituted quinazoline derivatives with enhanced potency for the treatment of EGFR T790M-mutant non-small-cell lung cancers | 10.1016/j.bioorg.2018.01.035 | 2018-02-15 | BIOORGANIC CHEMISTRY | 3.929 | Zhuo Liu, Luhong Wang, Min Feng, Yuanyuan Yi, Wenhan Zhang, Wenjuan Liu, Lei Li, Zhihao Liu, Yanxia Li, Xiaodong Ma |
| Synthesis and biological evaluation of azole-diphenylpyrimidine derivatives (AzDPPYs) as potent T790M mutant ｆorm of epidermal growth factor receptor inhibitors | 10.1016/j.bmc.2016.09.001 | 2016-09-03 | BIOORGANIC & MEDICINAL CHEMISTRY | 2.923 | Zhendong Song, Yue Jin, Yang Ge, Changyuan Wang, Jianbin Zhang, Zeyao Tang, Jinyong Peng, Kexin Liu, Yanxia Li, Xiaodong Ma |
热门标签：人肺腺癌细胞,NCI-H1975,NCI-H1975细胞
